Romiplostim therapy as a second-line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids.
about
Romiplostim therapy as a second-line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Romiplostim therapy as a secon ...... secondary to corticosteroids.
@ast
Romiplostim therapy as a secon ...... secondary to corticosteroids.
@en
type
label
Romiplostim therapy as a secon ...... secondary to corticosteroids.
@ast
Romiplostim therapy as a secon ...... secondary to corticosteroids.
@en
prefLabel
Romiplostim therapy as a secon ...... secondary to corticosteroids.
@ast
Romiplostim therapy as a secon ...... secondary to corticosteroids.
@en
P2860
P356
P1476
Romiplostim therapy as a secon ...... secondary to corticosteroids.
@en
P2093
Maria Carmen Peña-Cala
Teresa Casanovas Taltavull
P2860
P304
P356
10.1002/CCR3.667
P577
2017-01-23T00:00:00Z